Johnson & Johnson: all 3,718 studies

Page 20 of 38. Open to participants first (155), then studies with results posted, then the rest; newest registration first within each.

• A Clinical Study to Assess the Effect of Clopidogrel on the Pharmacokinetics of Selexipag and Its Active Metabolite in Healthy Male SubjectsCompletedNCT03496506Phase 1
• Prospective Observational Study on Ustekinumab (Stelara) Assessing Efficacy and Healthcare Resource Utilization in Crohn's DiseaseCompletedNCT03495973
• A Study to Evaluate the Effects of Single-dose Seltorexant on Electrocardiogram Intervals in Healthy Adult ParticipantsCompletedNCT03494907Phase 1
• A Study for Comparison of Canagliflozin Versus Alternative Antihyperglycemic Treatments on Risk of Heart Failure Hospitalization and Amputation for Participants With Type 2 Diabetes Mellitus and the Subpopulation With Established Cardiovascular DiseaseCompletedNCT03492580
• Study of ITI-214 in Healthy Volunteers to Determine CNS EngagementCompletedNCT03489772Phase 1
• Pediatric Microbiome Study With Children Now Approximately 8-10 Years Old.CompletedNCT03485755
• A Study of Fluoroquinolones Exposure and Collagen-Related Serious Adverse EventsCompletedNCT03479736
• Clinical Outcomes of Chronic Lymphocytic Leukemia (CCL) and Mantle Cell Lymphoma (MCL) Participants Treated With Ibrutinib: A Medical Chart Review From IndiaCompletedNCT03476655
• A Crossover Study to Assess the Drug-drug Interaction of Acid Reducing Agent(s) on the Pharmacokinetics of a Single Oral Dose of Lumicitabine (JNJ-64041575) in Healthy Adult ParticipantsTerminatedNCT03468777Phase 1
• A First-In-Human Study to Evaluate Safety, Tolerability, Reactogenicity, and Immunogenicity of JNJ-64300535, a DNA Vaccine, Administered by Electroporation-Mediated Intramuscular Injection, in Participants With Chronic Hepatitis B Who Are on Stable Nucleos(t)Ide Therapy and Virologically SuppressedCompletedNCT03463369Phase 1
• Evaluation of Two Regimens, With Healthy Male and Female Babies, Ages 3-6 Months Old, Using Various Assessments.CompletedNCT03457857Not applicable
• Health Partner Evaluation at ProvidenceTerminatedNCT03443284Not applicable
• A Crossover Study to Assess the Effect of Intravenous Infusion of Piperacillin/Tazobactam on the Pharmacokinetics of Orally Administered Lumicitabine (JNJ-64041575) in Healthy Adult ParticipantsCompletedNCT03441529Phase 1
• Biomarker Discovery in Two Daily Disposable Contact LensesCompletedNCT03440242
• A Study of Orally Administered JNJ-440 to Evaluate the Safety, Tolerability, and Pharmacokinetics After Single Ascending Doses Including Food Effect Evaluation; After Multi-Day Dosing in Healthy Participants; and After Multiple (Ascending) Doses in Participants With Chronic Hepatitis BCompletedNCT03439488Phase 1
• A Study to Compare Two Formulations of Xylometazoline/Dexpanthenol Nasal Spray for the Treatment of Nasal Congestion.CompletedNCT03439436Phase 3
• A Study to Evaluate the Relative Oral Bioavailability of Seltorexant (JNJ-42847922) After Administration of 3 Different Formulations in Healthy Participants Under Fasted and Semi-fasted ConditionsCompletedNCT03438461Phase 1
• A Positron Emission Tomography (PET) Study to Investigate P2X7 Receptor Occupancy by JNJ-55308942 Using [18F]-JNJ-64413739CompletedNCT03437590Phase 1
• A Study to Determine the Efficacy and Safety of a Benzocaine Lozenge for Treatment of Sore Throat.CompletedNCT03432923Phase 3
• A Study of Ibrutinib in the Treatment of Chronic Lymphocytic Leukemia and Mantle-cell Lymphoma in Routine Clinical PracticeCompletedNCT03425591
• A Clinical Study to Investigate the Long-term Safety of the Drug Macitentan in Patients With Pulmonary Hypertension Who Were Previously Treated With Macitentan in Clinical Studies.CompletedNCT03422328Phase 3
• A Study to Assess the Safety, Tolerability and Pharmacokinetics of Repeated Dosing Regimens of AL-794 in Healthy VolunteersTerminatedNCT03411421Phase 1
• A Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-55375515 in Healthy Male ParticipantsCompletedNCT03405441Phase 1
• A Study of TAR-200 in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder Who Are Ineligible for or Refuse Cisplatin-based Chemotherapy and Who Are Unfit for Radical CystectomyCompletedNCT03404791Phase 1
• A First-In-Human Study of Orally Administered JNJ-64417184 to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses, and the Antiviral Activity of Multiple Doses in a Respiratory Syncytial Virus (RSV) Challenge Study in Healthy ParticipantsCompletedNCT03403348Phase 1
• Dose Escalation Study of Talquetamab in Participants With Relapsed or Refractory Multiple MyelomaActive, not recruitingNCT03399799Phase 1
• A Study to Assess the Nicotine Pharmacokinetics, Tolerability and Safety With a New Oral Nicotine Replacement Product in Healthy Japanese SmokersCompletedNCT03398876Phase 1
• Clinical Study to Investigate Effect of Macitentan on Riociguat PharmacokineticsCompletedNCT03389321Phase 1
• Randomized, Double-Blind, Placebo-Controlled, Safety and Tolerability Study of ITI-214 in Patients With Heart FailureCompletedNCT03387215Phase 1/2
• Health Partner Evaluation at PrincetonTerminatedNCT03386786Not applicable
• A Study to Evaluate the Efficacy and Safety of Bedaquiline (TMC207) in Participants With Multibacillary LeprosyCompletedNCT03384641Phase 2
• A Study to Quantify Use of Anticoagulation to Improve Management of Atrial FibrillationTerminatedNCT03382613
• A Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-63733657 in Healthy Subjects and Subjects With Alzheimer's DiseaseCompletedNCT03375697Phase 1
• A Study to Investigate the Antidepressant Mechanism-of-action of JNJ-42847922 in Participants With Major Depressive DisorderCompletedNCT03374475Phase 1
• Treatment-Resistant Depression Cohort in EuropeCompletedNCT03373253
• An Early Access Program For Ustekinumab In Participants With Moderately To Severely Active Crohn's DiseaseNo longer availableNCT03362736
• Clinical Study to Investigate the Effect of Macitentan on the Concentrations of Rosuvastatin in the Blood of Healthy Male SubjectsCompletedNCT03359291Phase 1
• A Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants With Active Crohn's Disease or Ulcerative ColitisTerminatedNCT03358706Phase 1
• A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Ad26.ZIKV.001 in Healthy Adult VolunteersCompletedNCT03356561Phase 1
• A Study to Investigate the Safety, Tolerability and Pharmacokinetics of JNJ-64991524 in Healthy ParticipantsCompletedNCT03346122Phase 1
• A Study to Characterize Profile of Participant With Psoriatic Arthritis Depending on Whether Their Disease is Managed by a Dermatologist or by a Rheumatologist, and Starting UstekinumabCompletedNCT03336281
• A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-54767414 (Daratumumab) in Healthy ParticipantsCompletedNCT03320707Phase 1
• A Study of 2 Different Regimens of Tetravalent Ad26.Mos4.HIV Prime Followed by Boost With Modified Vaccinia Ankara (MVA)-Mosaic OR Ad26.Mos4.HIV Plus a Combination of Mosaic and Clade C gp140 Protein in Human Immunodeficiency Virus (HIV) Type 1 Infected Adults on Suppressive Antiretroviral TreatmentCompletedNCT03307915Phase 1
• A Study to Evaluate the Effect of Ibrutinib on the Pharmacokinetics of Oral Contraceptives, CYP2B6, and CYP3A4 Substrates in Female Participants With B Cell MalignancyCompletedNCT03301207Phase 1
• A Study to Assess the Effect of Ticlopidine on the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered Esketamine in Healthy ParticipantsCompletedNCT03298906Phase 1
• A Study to Evaluate SIMPONI (Golimumab) Therapy in Children, Adolescents and Young Adults With Pre-Symptomatic Type 1 DiabetesCompletedNCT03298542Phase 1
• A Study of AL-034 to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses in Healthy ParticipantsCompletedNCT03285620Phase 1
• A Registry for Patients Taking UptraviCompletedNCT03278002
• A Study to Investigate the Pharmacokinetics, Safety, and Tolerability of Odalasvir and AL-335 Alone and in Combination With Simeprevir in Participants With Moderately Impaired Hepatic FunctionWithdrawnNCT03277755Phase 1
• A Study to Evaluate Bioequivalence and Adhesion of a Transdermal Contraceptive Patch Manufactured With Newly Sourced Adhesive Components and Currently Marketed EVRA in Healthy Adult WomenCompletedNCT03274297Phase 4
• A Study to Investigate the Regional Brain Kinetics of the Positron Emission Tomography Ligand [18F]JNJ-64511070CompletedNCT03270579Phase 1
• An 8-week Full Face HUT Clinical Trial for HydroBoost (2.0/3.0)CompletedNCT03264677Not applicable
• Clinical Study to Assess Bioequivalence Between Nicorette Extra Mint Gum and Nicorette® Mint Gum in Healthy SmokersCompletedNCT03259607Phase 1
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ITI-214 in Parkinson's DiseaseCompletedNCT03257046Phase 1/2
• A Dose-escalation, Expansion Study of ARX788, in Advanced Solid Tumors Subjects With HER2 Expression (ACE-Pan Tumor 01)CompletedNCT03255070Phase 1
• A First in Human Study of AL-611 in Healthy Volunteers and Patients With Hepatitis C Virus InfectionTerminatedNCT03253471Phase 1
• Cardiovascular Outcomes in Participants With Type 2 Diabetes Mellitus (T2DM)CompletedNCT03249506
• A Study to Evaluate the Effect of Multiple Oral Doses of JNJ-42847922 on the Steady-state Pharmacokinetics of an Oral Contraceptive Containing Ethinyl Estradiol and Levonorgestrel in Healthy Female Adult ParticipantsCompletedNCT03249402Phase 1
• A Study of Subcutaneous Delivery of JNJ-54767414 (Daratumumab) in Japanese Participants With Relapsed or Refractory Multiple MyelomaCompletedNCT03242889Phase 1
• Evaluation of Tau Protein in the Brain of Participants With Alzheimer's Disease Compared to Healthy ParticipantsCompletedNCT03239561Early Phase 1
• A Phase 1b Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of JNJ-64565111 in Participants With Type 2 Diabetes MellitusCompletedNCT03235219Phase 1
• A Study to Compare Daratumumab, Bortezomib, and Dexamethasone (DVd) vs Bortezomib and Dexamethasone (Vd) in Chinese Participants With Relapsed or Refractory Multiple MyelomaCompletedNCT03234972Phase 3
• Bioequivalence Study of Xian Risperdal Tablets Compared With Gurabo Risperdal Tablets Under Fasting and Fed Conditions in Chinese Healthy ParticipantsWithdrawnNCT03220867Phase 1
• A Safety Study of Ustekinumab in the Treatment of Pediatric Participants Aged 6 Years and Older With Moderate to Severe Plaque PsoriasisActive, not recruitingNCT03218488
• A Study of VELCADE (Bortezomib) Melphalan-Prednisone (VMP) Compared to Daratumumab in Combination With VMP (D-VMP), in Participants With Previously Untreated Multiple Myeloma Who Are Ineligible for High-Dose Therapy (Asia Pacific Region)CompletedNCT03217812Phase 3
• A Study to Compare the Macitentan-tadalafil Fixed Dose Combination Tablet Relative to the Concomitant Administration of the Reference Tablets of Macitentan and Tadalafil in Healthy SubjectsCompletedNCT03215966Phase 1
• A Bioequivalence Study Between Two Brands of Medications to Treat Cough & Cold SymptomsCompletedNCT03213353Phase 1
• Treatment Resistant Depression in America LatinaCompletedNCT03207282
• Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United StatesCompletedNCT03197688
• A Study to Assess the Bioequivalence of Xisimin (Loratadine) Tablets Under Fasting and Fed Conditions in Healthy Participants Compared With Clarityne TabletsCompletedNCT03196531Phase 1
• DSJ-2016-07 ATTUNE® Cementless CR RP JapanCompletedNCT03193034Not applicable
• A Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics of JNJ-64041575 in Adult Participants With Various Degrees of Renal FunctionCompletedNCT03189498Phase 1
• Cup Position in THA With Standard InstrumentsCompletedNCT03189303
• Capillary And Venous Accuracy: LifeScan Products vs Hospital Reference and YSICompletedNCT03189225Not applicable
• Multiple Myeloma Patient RegistryTerminatedNCT03180853
• A Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-64140284 in Healthy ParticipantsTerminatedNCT03180762Phase 1
• Safety and Tolerability of TAR-302-5018 in Subjects With Neurogenic Detrusor Overactivity Resulting From Spinal Cord InjuryCompletedNCT03168828Phase 1
• A Study to Evaluate the Cardiac Safety of a Single Dose of AL-335 Administered on a Background of Simeprevir and Odalasvir and of Repeated Doses of Odalasvir Administered Alone in Healthy ParticipantsCompletedNCT03155893Phase 1
• ATTUNE Revision System in the Revision Total Knee Arthroplasty PopulationActive, not recruitingNCT03153475Not applicable
• ATTUNE® Revision- Complex Primary in Total Knee Arthroplasty PopulationActive, not recruitingNCT03153449Not applicable
• A Study to Assess the Relative Bioavailability of Xisimin (Loratadine) Tablets Under Fasting and Fed Conditions in Healthy Participants Compared to Clarityne TabletsCompletedNCT03151720Phase 1
• A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-55308942 in Healthy Male and Female ParticipantsCompletedNCT03151486Phase 1
• Dose Escalation Study of Teclistamab, a Humanized BCMA*CD3 Bispecific Antibody, in Participants With Relapsed or Refractory Multiple MyelomaActive, not recruitingNCT03145181Phase 1
• Treatment of Advanced Dry Age Related Macular Degeneration With AAVCAGsCD59CompletedNCT03144999Phase 1
• Optimizing Clinical Screening and Management of Maternal Mental Health: Predicting Women at Risk for Perinatal DepressionCompletedNCT03144752
• UK Baby Study Using a Baby Wash and Lotion RegimenTerminatedNCT03142984Not applicable
• A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-61803534 and to Evaluate the Effect of JNJ-61803534 on the Pharmacokinetics of Midazolam in Healthy ParticipantsTerminatedNCT03139500Phase 1
• OneTouch Verio Flex System Accuracy EvaluationCompletedNCT03138174
• A Study to Evaluate the Effect of Fluconazole and Itraconazole on Erdafitinib Pharmacokinetics in Healthy Adult ParticipantsCompletedNCT03135106Phase 1
• A Study in Participants With a Newly Confirmed Diagnosis of Spondyloarthritis (SpA) Who Are New to Conventional, Targeted and Biological DMARDsCompletedNCT03131661
• A Bioequivalence Study Between Two Nicotine Replacement Therapies in Adult Healthy Smokers Motivated to Quit.CompletedNCT03130179Phase 1
• A Study to Investigate the Effect of Different Particle Sizes on the Single-dose Pharmacokinetics of Rilpivirine After Intramuscular Injection of a Long-acting Nanosuspension in Healthy ParticipantsCompletedNCT03127189Phase 1
• A Study to Investigate the Interaction Between JNJ-64155806 and Ethinylestradiol/Drospirenone in Healthy FemalesTerminatedNCT03126097Phase 1
• A Study Evaluating AL-3778 in Combination With Peginterferon Alpha-2a in Chronic Hepatitis B SubjectsWithdrawnNCT03125213Phase 2
• A Study in Healthy Female Participants to Investigate the Effect of JNJ-56136379 at Steady-state on the Single-dose Pharmacokinetics of Ethinylestradiol and Drospirenone (Oral Contraceptive) and on the Single-dose Pharmacokinetics of Midazolam (Probe Substrate for Cytochrome P450 3A4)CompletedNCT03111511Phase 1
• Safety and Tolerability of TAR-302-5018 in Subjects With Idiopathic Overactive BladderCompletedNCT03109379Phase 1
• An Epidemiology Study of Treatment Resistant Depression in the United States (US)CompletedNCT03109002
• A Phase 1 Study to Evaluate the Effect of the Organic Anion Transporter Inhibitor Probenecid on the Pharmacokinetics of JNJ-64041575 in Healthy AdultsCompletedNCT03105986Phase 1
• A Long Term Follow-up Study in Participants Treated in a Preceding Phase 2 or 3 Study With a Regimen Containing Odalasvir and AL-335 With or Without Simeprevir for the Treatment of Hepatitis C Virus (HCV) InfectionTerminatedNCT03099135Phase 3
• A Study to Investigate the Regional Brain Kinetics of Brain Drug Transporters Using P-glycoprotein and Breast Cancer Resistance Protein Substrates and by Using the Positron Emission Tomography Ligand 11C-JNJ-63779586 in the Human BrainCompletedNCT03089918Phase 1

← Johnson & Johnson overview and focus areas